Non-invasive Ultrasound Retinal Stimulation for Vision Restoration
NCT05914233 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2026-01-08
Summary
This clinical trial aims to test the safety and feasibility of using a non-invasive ultrasound device to stimulate retinal nerve cells and restore vision in patients with age-related macular degeneration. Previous studies have shown that artificial stimulation, such as electric and optic stimulations, can partially restore vision, but these methods are invasive and pose surgical risks. The study aims to develop a non-invasive method for retinal stimulation. The investigators will follow the FDA guidelines to limit the ultrasound power and adhere to all clinical trial regulations to ensure all participants' safety.
The main questions the investigators aim to answer are:
* Is using high-frequency ultrasound safe using a wearable device for localized retinal neural activity stimulation?
* Does the stimulation through the device restore vision in patients with age-related macular degeneration?
Participants in this study will be asked to undergo Optical Coherence Tomography (OCT) scanning before and after the ultrasound stimulation to evaluate the device's safety. Then, they will receive five stimulation-rest cycles and complete a questionnaire to report what they see and how they feel during the device's operation.
Conditions
- Age-Related Macular Degeneration
- Retinitis Pigmentosa
- Ultrasound Therapy; Complications
Interventions
- DEVICE
-
Non-invasive ultrasound retinal stimulation Device
Record user feelings during the device is working
Sponsors & Collaborators
-
University of Southern California
lead OTHER
Principal Investigators
-
Qifa Zhou, PhD · University of Southern California
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2027-01-10
- Primary Completion
- 2028-01-15
- Completion
- 2028-07-15
More Related Trials
-
Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion
NCT00913744 ·Status: COMPLETED ·Phase: PHASE2
-
Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma
NCT05706896 ·Status: RECRUITING ·Phase: NA
-
Proton Radiation Therapy for Macular Degeneration
NCT01833325 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa
NCT06242379 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)
NCT05275205 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration
NCT00996684 ·Status: UNKNOWN ·Phase: PHASE2
-
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
NCT05197270 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection
NCT02713204 ·Status: COMPLETED ·Phase: PHASE2
-
Recurrent Neovascular Age-related Macular Degeneration After Therapy Suspension
NCT04659512 ·Status: COMPLETED
-
Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration
NCT00220805 ·Status: COMPLETED ·Phase: PHASE2
-
RBM-007 in Treatment naïve Exudative Age-related Macular Degeneration
NCT04895293 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Tolerability of OCU-10-C-110 for Injection in Subjects With Neovascular Age-related Macular Degeneration
NCT05904691 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)
NCT01482910 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration
NCT00090532 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
NCT01722045 ·Status: COMPLETED ·Phase: PHASE4
-
Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes
NCT01846351 ·Status: COMPLETED
-
Research With Retinal Cells Derived From Stem Cells for Myopic Macular Degeneration
NCT02122159 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD
NCT00383370 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration
NCT00001615 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Intravitreally Administered AIV007 in Subjects With Neovascular Age-Related Macular Degeneration
NCT04422899 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration
NCT02087085 ·Status: TERMINATED ·Phase: PHASE2
-
Non-exudative Age-related Macular Degeneration
NCT01712841 ·Status: COMPLETED
-
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
NCT01535950 ·Status: COMPLETED ·Phase: PHASE2
-
Intravitreal Bone Marrow-Derived Stem Cells in Patients With Macular Degeneration
NCT01518127 ·Status: COMPLETED ·Phase: NA
-
UGX202 Injection in Patients With Advanced Retinitis Pigmentosa
NCT07311863 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1